ea921179304f710bc0db5bf2ad98b95b

CEFUROXIME

BIOMERIEUX SA·II·Colombia INVIMA·Expires January 01, 2033
Device classification
Risk class / Clase de Riesgo
II
Product type (Spanish)
REACTIVO DIAGNOSTICO
Product type (English)
DIAGNOSTIC REAGENT
Registration information
Analysis ID
ea921179304f710bc0db5bf2ad98b95b
Expire date
January 01, 2033
Authorized company / Fabricante
Name (Spanish)
BIOMERIEUX SA
Name (English)
BIOMERIEUX SA
Product use / Uso del Producto
Spanish

ETEST® ES UNA TÉCNICA CUANTITATIVA MANUAL PARA LA DETERMINACIÓN DE LA SUSCEPTIBILIDAD ANTIMICROBIANA DE LAS BACTERIAS_x000D_ AEROBIAS GRAMPOSITIVAS Y GRAMNEGATIVAS NO EXIGENTES Y BACTERIAS EXIGENTES. EL SISTEMA COMPRENDE UN GRADIENTE DE_x000D_ ANTIBIÓTICO PREDEFINIDO QUE SE UTILIZA PARA DETERMINAR LA CONCENTRACIÓN MÍNIMA INHIBITORIA (CMI, EN µG/ML) DE DIFERENTES_x000D_ AGENTES ANTIMICROBIANOS FRENTE A MICROORGANISMOS SEMBRADOS EN MEDIO DE AGAR TRAS UNA NOCHE DE INCUBACIÓN._x000D_

English

ETEST® IS A MANUAL QUANTITATIVE TECHNIQUE FOR DETERMINING THE ANTIMICROBIAL SUSCEPTIBILITY OF BACTERIAS_x000D_ GRAM-POSITIVE AND GRAM-NEGATIVE NON-DEMANDING AEROBES AND DEMANDING BACTERIA. THE SYSTEM COMPRISES A GRADIENT DE_x000D_ A PREDEFINED ANTIBIOTIC USED TO DETERMINE THE MINIMUM INHIBITORY CONCENTRATION (MIC, IN μG/ML) OF DIFERENTES_x000D_ ANTIMICROBIAL AGENTS AGAINST MICROORGANISMS PLANTED IN AGAR MEDIUM AFTER A NIGHT OF INCUBACIÓN._x000D_

About this record

Access comprehensive regulatory information for CEFUROXIME (CEFUROXIME) in the Colombia medical device market through Pure Global AI's free database. This II medical device is registered under INVIMA analysis ID ea921179304f710bc0db5bf2ad98b95b and manufactured by BIOMERIEUX SA. The device was registered on January 01, 2033.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.